FDA Approves Radicava (edaravone) to Treat Amyotrophic Lateral Sclerosis (ALS)

May 5, 2017 -- The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig ’s disease. “After learning about the use of edaravone to...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news